Citalopram Concept

subject area of

• 12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder  Academic Article
• A Randomized Controlled Trial of Antidepressant Continuation for Major Depression Following Traumatic Brain Injury  Academic Article
• A Retrospective Assessment of Citalopram in Children and Adolescents with Pervasive Developmental Disorders  Academic Article
• A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial  Academic Article
• Amygdala responses to quetiapine XR and citalopram treatment in major depression: the role of 5-HTTLPR-S/Lg polymorphisms  Academic Article
• An Open Trial of Adjunctive Escitalopram in Bipolar Depression  Academic Article
• An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report  Academic Article
• An open-label study of citalopram for major depression following traumatic brain injury  Academic Article
• Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report  Academic Article
• Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report  Academic Article
• Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1  Academic Article
• Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines  Academic Article
• Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort  Academic Article
• Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report  Academic Article
• Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study  Academic Article
• Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study  Academic Article
• Functional Dyspepsia Treatment Trial (FDTT): A double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics  Academic Article
• Genetic markers anticipate response to citalopram in a majority of patients  Academic Article
• Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury  Academic Article
• Gut Microbiome Patterns Associated With Treatment Response in Patients With Major Depressive Disorder: Changements du microbiote intestinal associés à la réponse au traitement chez des patients souffrant de trouble dépressif majeur  Academic Article
• Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report  Academic Article
• Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra  Academic Article
• Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants  Academic Article
• Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project  Academic Article
• Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response  Academic Article
• Maintenance or Discontinuation of Antidepressants in Primary Care  Academic Article
• Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report  Academic Article
• Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 report  Academic Article
• Persistent genital arousal disorder: a clinical challenge  Academic Article
• Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial  Academic Article
• Rates of Anomalous Bupropion Prescriptions in Ontario, Canada  Academic Article
• Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study  Academic Article
• Role of serotonin transporter inhibition in the regulation of tryptophan hydroxylase in brainstem raphe nuclei: time course and regional specificity  Academic Article
• Serotonin Agents in the Treatment of Acquired Brain Injury  Academic Article
• Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression  Academic Article
• Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder  Academic Article
• Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series  Academic Article
• Symptom-onset dosing with citalopram in the treatment of premenstrual dysphoric disorder (PMDD): a case series  Academic Article
• Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder  Academic Article
• The 5-HTTLPR and BDNF polymorphisms moderate the association between uncinate fasciculus connectivity and antidepressants treatment response in major depression  Academic Article
• The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study  Academic Article
• The role of hormone therapy in the management of severe postpartum depression in patients with Turner syndrome  Academic Article
• Topiramate augmentation in a patient with obsessive–compulsive disorder  Academic Article
• Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response  Academic Article
• Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression  Academic Article